Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Diabetes|December 1, 1995
NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic communityJ A Pugh, R A Medina, J C Cornell, et al.Anticancer Research|January 1, 1993
Growth inhibitory substances in human breast cyst fluidL C Lai, C T Chan, C Cornell, et al.Cutis|October 1, 1980
Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgarisR B Stoughton, R C Cornell, R W Gange, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|June 30, 1987
Serum human pancreatic elastase I levels in pancreatic diseaseP K Buamah, C Cornell, A J Cassells-Smith, et al.Archives of Dermatology|December 1, 1976
Anemia of azaribine in the treatment of psoriasisR C Cornell, H G Milstein, R M Fox, et al.Behavior Analysis in Practice|October 11, 2021
Adventures in Direct Instruction Implementation: The Devil Is in the DetailsJoel L Vidovic, Mary C Cornell, Sarah E Frampton, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1987
Differential reactivity of alpha-fetoprotein with lectins and its usefulness in the diagnosis of various liver diseasesP K Buamah, C Cornell, A J Cassells-Smith, et al.The Journal of Investigative Dermatology|April 1, 1979
Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnesW W Crawford, I P Crawford, R B Stoughton, et al.The British Journal of Dermatology|May 1, 1979
Plasma complement and histamine changes in atopic dermatitisJ Ring, T Senter, R C Cornell, et al.The British Journal of Dermatology|November 1, 1978
Complement and immunoglobulin deposits in the skin of patients with atopic dermatitisJ Ring, T Senter, R C Cornell, et al.Pageof 7